(Press-News.org) Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment — an immunotherapy that uses modified patient T cells to target cancer. The study used CRISPR screening to pinpoint genes that influenced T cell function and survival in culture and in a preclinical model of multiple myeloma. Their results and technique, published in Nature, could lead to T cell-based immunotherapies for cancer.
“We performed a screen over the entire lifecycle of a T cell, co-culturing them with cancer cells, and then took the work a step further by transferring the cells to an animal model,” said co-senior author Robert Manguso, PhD, a researcher at the Krantz Family Center for Cancer Research at Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, and director of the Tumor Immunotherapy Discovery Engine at Broad. “We discovered important regulators in vivo that we could not have predicted from the in vitro results.”
“Testing individual genetic modifications to find those that enhance CAR-T function would take a huge amount of time and money. Our approach lets us test hundreds of changes at a time,” added co-senior author Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program at the Mass General Brigham and an associate member in the Broad's Cancer Program.
CAR-T cell therapy has revolutionized the treatment of blood cancers but, thus far, has not been as effective against solid tumors or in patients with relapsed or refractory multiple myeloma. In addition, the number of circulating CAR-T cells decreases over time, limiting their long-term activity.
In this federally funded study, the research team developed a CRISPR screen that targeted 135 genes in human donor-derived CAR-T cells to identify genes that may improve persistence and function. The investigators cultured the CRISPR-edited cells in vitro, transferred them into a mouse model of multiple myeloma and tracked their survival in vivo for up to 21 days.
Analyses of the modified CAR-T cells revealed that deleting the cell cycle regulator gene CDKN1B increased CAR-T cell proliferation, long-term persistence and anti-tumor activity. The researchers also observed that some genes affected function in vitro but not in vivo, while others boosted early proliferation in the tumor microenvironment but did not provide long-term benefits.
The authors propose that targeting CDKN1B in CAR-T cells could enhance treatment outcomes for patients with multiple myeloma and suggest that future studies that harness their screening method could refine therapeutics for other cancers.
Authorship: In addition to Maus and and Manguso, authors include Nelson H. Knudsen, Giulia Escobar, Felix Korell, Tamina Kienka, Celeste Nobrega, Seth Anderson, Andrew Y. Cheng, Maria Zschummel, Alexander Armstrong, Amanda Bouffard, Michael C. Kann, Sadie Goncalves, Hans W. Pope, Mitra Pezeshki, Alexander Rojas, Juliette S. M. T. Suermondt, Merle Phillips, Trisha R. Berger, Sangwoo Park, Diego Salas-Benito, Elijah P. Darnell, Filippo Birocchi, Mark B. Leick, Rebecca C. Larson, John G. Doench, Debattama Sen, and Kathleen B. Yates.
Paper cited: Knudson NH et al. “In vivo CRISPR screens identify modifiers of CAR-T cell function in myeloma” Nature DOI: 10.1038/s41586-025-09489-8
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Recent studies suggest that the steady rise in life expectancy observed over the past 200 years has now stagnated. Data indicate that a limit has been reached, and that medical and healthcare advances no longer affect longevity in developed countries as they did in previous decades. Today, ageing itself, rather than disease, is the real frontier of human longevity. But what exactly is ageing? And can it be addressed in the same way as a disease?
A team led by Dr Manel Esteller, Head of the Cancer Epigenetics group at the Josep Carreras Leukaemia Research Institute, has just ...
Embargoed for release: Wednesday, September 24, 2025, 11:00 AM ET
Key points:
By their 18th birthday, 61% of U.S. children have relied on Medicaid or the Children’s Health Insurance Program (CHIP), and 42% have experienced gaps in coverage, according to estimates from a microsimulation model.
Disruptions to insurance coverage were more common among children covered by Medicaid or CHIP at birth in states that did not expand their Medicaid adult programs. States that set the most restrictive income eligibility thresholds for children under Medicaid and CHIP saw the highest share of coverage disruptions.
The ...
Hospitals with the widest difference between the cost of their services and what they charge patients and their insurance carriers are mostly for-profit, investor owned and located in large metropolitan areas. They also have significantly worse patient outcomes compared with lower-cost hospitals, new UCLA research finds.
These “high-markup hospitals” (HMH), which comprised about 10% of the total the researchers examined, charged up to 17 times the true cost of care. By contrast, markups at other hospitals were an average of three times the cost of care.
The findings will be published September ...
The research team conducted an in-depth study of the evolution and domestication of barley (Hordeum vulgare). They focused on so-called haplotypes - sections of DNA that are inherited together and act like genetic “building blocks.” To trace barley’s history, the scientists analysed the genetic material of 682 barley accessions from the IPK genebank and 23 archaeological barley finds, including ancient charred grains up to 6,000 years old.
The team specifically studied 380 wild barley samples from regions across western and central Asia, and compared them with 302 samples ...
During the course of evolution, the mammalian cranio-mandibular secondary joint—formed by the dentary condyle and the squamosal glenoid fossa, which replaced the reptilian articular–quadrate joint—represents an innovative structure in vertebrate evolution. By CT-scanning two classic fossils, Chinese researchers found previously unknown jaw joints and proposed a clear, four-step sequence showing how chewing and hearing functions were gradually split between jaw and ear.
The research was led by Prof. MAO Fangyuan from the Institute of Vertebrate Paleontology and Paleoanthropology of ...
UNSW Sydney nano-tech startup Diraq has shown its quantum chips aren’t just lab-perfect prototypes – they also hold up in real-world production, maintaining the 99% accuracy needed to make quantum computers viable.
Diraq, a pioneer of silicon-based quantum computing, achieved this feat by teaming up with European nanoelectronics institute Interuniversity Microelectronics Centre (imec). Together they demonstrated the chips worked just as reliably coming off a semiconductor chip fabrication line as they do in the experimental conditions of a research ...
Traditionally, chemical reactions have been described as one-line “equations” in which substrates, say A and B, convert purposefully but rigidly into a desired product, say C. Naturally, it has been recognized that byproducts may also form, but these have been generally considered undesirable and unproductive. The current research demonstrates that this view is very fragmentary and insufficient: in reality, chemical reactions – even those studied since the 19th century – are complex reactivity networks that, depending on the concentrations of ...
A team of researchers from the University of Science and Technology of China and the Zhongguancun Institute of Artificial Intelligence has developed SciGuard, an agent-based safeguard designed to control the misuse risks of AI in chemical science. By combining large language models with principles and guidelines, external knowledge databases, relevant laws and regulations, and scientific tools and models, SciGuard ensures that AI systems remain both powerful and safe, achieving state-of-the-art defense against malicious use ...
“These results highlight potential mechanisms by which loss of p53 function contributes to an immunosuppressive microenvironment in HGSC, and provide insight into the role of ovarian and peritoneal microenvironments in regulating HGSC cell-intrinsic inflammatory signaling.”
BUFFALO, NY – September 24, 2025 – A new research paper was published in Volume 16 of Oncotarget on September 22, 2025, titled “Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic ...
For over 100 years, teddy bears have been a hallmark of childhood nurseries, ubiquitously embedded in our early memories and rarely the object of deep scrutiny. However, according a recent article in BioScience by Dr. Nicolas Mouquet (CRNS) and colleagues, the humble teddy bear is much more than a mere plaything. Instead, the authors suggest that the beloved plushes play a pivotal role in our early conception of nature, potentially shaping the ways we interact with the natural world throughout our lives.
...
